...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

"I hold little promise of any windfall for us."

 

fair enough, trouble understanding why you havent sold all your rv x & zen & moved it all into Bti?

Your confident that rocket is going to the "da moon" jump on & hang on if thats where your heart & mind r at.

 

Share
New Message
Please login to post a reply